Royal Bank of Canada’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,500
| Closed | -$38K | – | 6498 |
|
|
2024
Q4 | $38K | Buy |
+17,500
| New | +$38K | ﹤0.01% | 5333 |
|
|
2024
Q3 | – | Sell |
-159
| Closed | – | – | 6560 |
|
|
2024
Q2 | $0 | Sell |
159
-248,341
| -100% | – | ﹤0.01% | 6769 |
|
|
2024
Q1 | $937K | Buy |
248,500
+48,252
| +24% | +$182K | ﹤0.01% | 3128 |
|
|
2023
Q4 | $654K | Sell |
200,248
-9,752
| -5% | -$31.9K | ﹤0.01% | 3537 |
|
|
2023
Q3 | $689K | Buy |
210,000
+189,954
| +948% | +$623K | ﹤0.01% | 3317 |
|
|
2023
Q2 | $90K | Sell |
20,046
-18,954
| -49% | -$85.1K | ﹤0.01% | 4975 |
|
|
2023
Q1 | $188K | Hold |
39,000
| – | – | ﹤0.01% | 4315 |
|
|
2022
Q4 | $122K | Sell |
39,000
-86
| -0.2% | -$269 | ﹤0.01% | 4839 |
|
|
2022
Q3 | $127K | Buy |
39,086
+86
| +0.2% | +$279 | ﹤0.01% | 4666 |
|
|
2022
Q2 | $140K | Sell |
39,000
-11,000
| -22% | -$39.5K | ﹤0.01% | 4631 |
|
|
2022
Q1 | $205K | Buy |
50,000
+39,440
| +373% | +$162K | ﹤0.01% | 4595 |
|
|
2021
Q4 | $57K | Buy |
+10,560
| New | +$57K | ﹤0.01% | 5770 |
|